A61P 43 - Drugs for specific purposes, not provided for in groups

Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
12/2009
12/03/2009	US20090297579 Control of Cells and Cell Multipotentiality in Three Dimensional Matrices
12/03/2009	US20090297501 Structural Isomers of sc(Fv)2
12/03/2009	US20090297495 Hydrolases, nucleic acids encoding them and methods for improving paper strength
12/03/2009	US20090297452 Method for quantification of neurotoxin
12/03/2009	US20090297451 Infection model for developing chemotherapeutic agents
12/03/2009	CA2729812A1 Therapeutic agent for alzheimer's disease
12/03/2009	CA2726231A1 Uses of conglutin-y
12/03/2009	CA2725307A1 Novel benzothiophene oxide derivative and salt thereof
12/03/2009	CA2725111A1 Substituted carbinol compound having a cyclic linker
12/03/2009	CA2724502A1 Adhesive preparation containing donepezil, and package of the same
12/03/2009	CA2720333A1 Manufacture, transport and delivery of material containing highly polarized nuclei
12/02/2009	EP2128272A1 Gene/protein marker for prediction or diagnosis of pharmacological efficacy of aurora a inhibitor
12/02/2009	EP2128248A1 Oligonucleotide compositions with enhanced efficiency
12/02/2009	EP2128171A1 Agent for prevention or treatment of iron overload
12/02/2009	EP2128154A1 Benzimidazole compound and pharmaceutical use thereof
12/02/2009	EP2128148A1 Compound, alpha 1 adrenaline receptor antagonist, and composition
12/02/2009	EP2128138A1 Pyrazole compound
12/02/2009	EP2128136A1 2-phenylnicotinic acid derivative
12/02/2009	EP2128134A1 Sulfonylurea derivative capable of selectively inhibiting mmp-13
12/02/2009	EP2128123A1 Salt of nonsteroidal anti-inflammatory drug and organic amine compound and use thereof
12/02/2009	EP2127675A1 Antiviral agent
12/02/2009	EP2127672A1 Inhibitor of herpesvirus infection, method for inhibition of herpesvirus infection, and use thereof
12/02/2009	EP2127662A1 Rankl production inhibitor
12/02/2009	EP2127648A1 Pharmaceutical formulations of amyloid inhibiting compounds
12/02/2009	EP2127646A1 Agent for relief or prevention of xerostomia
12/02/2009	EP2125036A1 Formation and rejuvenation of organs and alcohol damaged organ regeneration through stem cell nutrients
12/02/2009	EP2125029A2 Construction and use of transfection enhancer elements
12/02/2009	EP2124951A1 5-cyan0-4- (pyrrolo ý2, 3b¨pyridine-3-yl) -pyrimidine derivatives useful as protein kinase inhibitors
12/02/2009	EP2124930A1 Isosorbide mononitrate derivatives for the treatment of intestinal disorders
12/02/2009	EP1551802B1 Indole-3-sulphur derivatives
12/02/2009	EP1523321B1 Use of ginkgo biloba extracts in order to promote muscle mass to the detriment of fatty mass
12/02/2009	EP1463440B1 Prevention of flap necrosis in plastic surgery
12/02/2009	EP1434765B1 Substituted piperidines with selective binding to histamine h3-receptor
12/02/2009	EP1392683B1 Substituted 4h-chromenes and analogs as activators of caspases and inducers of apoptosis and their use as anticancer agents
12/02/2009	EP1389203B1 Analogs of thalidomide as angiogenesis inhibitors
12/02/2009	EP1349841B1 Anilinopyrimidine derivatives as ikk inhibitors and compositions and methods related thereto
12/02/2009	EP1309726B1 Rna sequence-specific mediators of rna interference
12/02/2009	EP1248804B2 Recombinant antibodies to human interleukin-1 beta
12/02/2009	CN101594883A Diagnosis and treatment of cancer using anti-EREG antibody
12/02/2009	CN101594860A Adam inhibitor
12/02/2009	CN101591319A Flavonoid derivatives and application thereof in preparing medicinal composition
12/02/2009	CN101591288A Cytochalasin compounds and preparation method and application thereof
12/02/2009	CN101590237A Composition containing calcium channel blocker and folic acid as well as application thereof
12/02/2009	CN101590235A Composition containing calcium channel blocker and B vitamins as well as application thereof
12/02/2009	CN101590234A Composition containing statins and B vitamins as well as application thereof
12/02/2009	CN101590233A Composition containing calcium channel blocker, statins and B vitamins as well as application thereof
12/02/2009	CN101590196A Chinese medicinal composition for clearing heat and releasing toxin, and dispelling damp heat
12/02/2009	CN101590123A Application of traditional Chinese medicine composition in preparing medicament for protecting damaged vascular endothelium
12/02/2009	CN101590120A Application of traditional Chinese medicine composition in preparing medicament for proliferating endothelial progenitor cells of peripheral blood of human body
12/02/2009	CN101590100A Traditional Chinese veterinary medicine injection for treating heatstroke of domestic animals and preparation method thereof
12/02/2009	CN101590070A Use of baicalin in preparation of targeted organ protection medicaments
12/02/2009	CN101590058A Medicinal composition containing dihydroergocryptine A mesylate
12/02/2009	CN101590057A Antitumor compositions containing taxane derivatives
12/02/2009	CN101590049A Composition containing amlodipine, atorvastatin and folic acid as well as new application thereof
12/02/2009	CN101590040A Composition containing indapamide and B vitamins as well as application thereof
12/02/2009	CN101590039A Composition containing indapamide and statins as well as application thereof
12/02/2009	CN101590036A Application of epoxydiene taken as inhibitor of proinflammatory mediators
12/02/2009	CN100564381C N-aryl diazaspiracyclic compounds and methods of preparation and use thereof
12/02/2009	CN100564378C Pyrrolidine oxadiazole- and thiadiazole derivatives
12/02/2009	CN100564377C Substituted 4H-chromenes and analogs as activators of caspase and inducers of apoptosis and use thereof
12/02/2009	CN100564375C (3Z) -3-(2,3-dihydro-1H-ylidene)-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors
12/02/2009	CN100563709C Novel targeted tissue factor antibody as anticoagulants
12/02/2009	CN100563656C Tamper-resistant oral opioid agonist
12/02/2009	CN100563653C Heterocyclic compounds which are active as inhibitors of beta lactamases
12/01/2009	US7626042 O-substituted hydroxyaryl derivatives
12/01/2009	US7626012 Nucleic acids encoding monoclonal antibody or an antigen-binding portion thereof that specifically binds to and activates human CD40; Gene therapy; nucleic acid coding immunoglobulins; anticancer agents
12/01/2009	US7625999 Immobilization on solid support
12/01/2009	US7625937 1H-benzo[F]indazol-5-YL derivatives as selective glucocorticoid receptor modulators
12/01/2009	US7625934 Metalloproteinase inhibitors
12/01/2009	US7625929 Oxophenyl-cyclohexyl-propanolamine derivatives, production and use thereof in therapeutics
12/01/2009	US7625925 Pyrazolo[1,5-a]pyridines and medicines containing the same
12/01/2009	US7625913 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease
12/01/2009	US7625892 Pharmaceutical compositions for the treatment of diseases related to neurotrophines
12/01/2009	US7625887 e.g. 2-[3,5-trans-5-(3-aminophenyl)-7-chloro-1-neopentyl-2-oxo-1,2,3,5-tetrahydro-4,1-benzoxazepin-3-yl]-N-(2-fluorobenzyl)acetamide; G-protein-coupled receptor (TGR5) agonist; central nervous system diseases; antiinflammatory agent; learning enhancement; angina pectoris, arrhythmia, bronchial asthma
12/01/2009	US7625883 Choline Salt of L- alpha -glycero-phospho-D-mio-inositol; alpha -glycero-phospho-D-mio-inositol tetrabutylammonium salt; treatment of pathologies mediated by the activation or over stimulation of cytololilc phospholipase-2 (PLA2), particularly, septic shock and viral and bacterial infections
12/01/2009	US7625875 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections
12/01/2009	US7625861 Copolymer-1 improvements in compositions of copolymers
12/01/2009	US7625860 Administering a combination of a cytotoxic agent and a fibroblastic growth factor antagonist, wherein the FGF antagonist enhances the efficacy of the cytotoxic agent
12/01/2009	US7625751 WNV core protein/capsid interacting protein and uses of the same
12/01/2009	US7625713 Process for identifying a ligand that binds to the NEP binding site for the SMR1 pentapeptide
12/01/2009	US7625710 Methods for determining 2F1-binding compounds
12/01/2009	US7625582 Methods for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor
12/01/2009	CA2492196C Sulfotransferase inhibitors
12/01/2009	CA2461100C 4-imidazolin-2-one compounds
12/01/2009	CA2432121C Nitric oxide synthase inhibitor phosphate salt
12/01/2009	CA2418348C Oil/fat composition
12/01/2009	CA2407210C Liposome drug delivery
12/01/2009	CA2389412C N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them
12/01/2009	CA2384718C Prostaglandin derivatives
12/01/2009	CA2264556C Substituted n-[(aminoiminomethyl or aminomethyl)phenyl]propyl amides
11/2009
11/26/2009	WO2009142745A2 Methods and compositions for treating hot flashes
11/26/2009	WO2009142321A1 Novel thiophenediamine derivative having urea structure
11/26/2009	WO2009142195A1 Agent for induction/maintenance of remission
11/26/2009	WO2009142184A1 Method of producing bicyclo[3.1.0]hexane derivative using enzyme
11/26/2009	WO2009142086A1 Vaccine composition for mycoplasma infection
11/26/2009	WO2009141965A1 Filtration method
11/26/2009	WO2009085277A3 Use of anti-connexin 43 polynucleotides for the treatment of abnormal or excessive scars
11/26/2009	US20090292016 Stable Pharmaceutical Compositions Containing Pravastatin
11/26/2009	US20090292002 Nucleotide and amino acid sequences relating to respiratory diseases and obesity
11/26/2009	US20090292000 Pyrrolidine derivatives as prostaglandin modulators

1 ... 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 ... 1564